Announcement on the Subsidiary Receiving the "Acceptance Notice" from the National Medical Products Administration for the Market Application of Betahistine Hydrochloride Tablets

About this update from Jointown Pharmaceutical Group Co., Ltd. Class A

Announcement on the Subsidiary Receiving the "Acceptance Notice" from the National Medical Products Administration for the Market Application of Betahistine Hydrochloride Tablets The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Jointown Pharmaceutical Group Co., Ltd. Class A